Wolverine Trading’s MiMedx Group MDXG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-16,116
Closed -$77K 5246
2022
Q1
$77K Buy
+16,116
New +$78.8K ﹤0.01% 4926
2021
Q4
Sell
-11,205
Closed -$77.8K 6456
2021
Q3
$70K Buy
+11,205
New +$126K ﹤0.01% 5923
2018
Q4
Sell
-45,978
Closed -$284K 4997
2018
Q3
$284K Buy
+45,978
New +$208K ﹤0.01% 3801
2017
Q4
Sell
-12,619
Closed -$150K 5256
2017
Q3
$150K Buy
12,619
+171
+1% +$2.54K ﹤0.01% 3933
2017
Q2
$185K Buy
+12,448
New +$166K ﹤0.01% 3640
2017
Q1
Sell
-13,031
Closed -$115K 4710
2016
Q4
$115K Buy
13,031
+2,157
+20% +$19.4K ﹤0.01% 4002
2016
Q3
$91K Sell
10,874
-18,457
-63% -$146K ﹤0.01% 4231
2016
Q2
$231K Buy
+29,331
New +$228K ﹤0.01% 3104

Other funds holding MDXG

Wolverine Trading's MDXG Position: Q2 2022 in Review

Wolverine Trading sold out of MiMedx Group (MDXG) in Q2 2022, closing a stake of 16,116 shares — an estimated $77K sold.

Wolverine Trading first reported a position in MDXG in Q2 2016 and held it in 8 quarters. The position peaked at $284K in Q3 2018. 153 funds tracked by Wall St. Rank hold MDXG as of Q2 2022.

  • Wolverine Trading reported no remaining MiMedx Group position as of Q2 2022 after selling out during the quarter.
  • Wolverine Trading sold 16,116 MiMedx Group shares in Q2 2022, an estimated $77K.
  • Wolverine Trading first reported a position in MiMedx Group in Q2 2016 and held it in 8 quarters.
  • Wolverine Trading's MiMedx Group position peaked at $284K in Q3 2018.
  • 153 funds tracked by Wall St. Rank held MiMedx Group as of Q2 2022.

Based on Wolverine Trading's 13F filing for Q2 2022, filed 15 Aug 2022.